• $57,185.00
    Market Cap
  • -99.97%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
09/30/2022
09/30/2021
Income Statement
Total Operating Revenue
2.1M
+228.66%
650,515
N/A
Cost of Revenue
766,558
+30.13%
589,056
N/A
Gross Profit
1.2M
+446.76%
-344,078
N/A
Sales and Marketing Expense
594,874
-66.54%
1.8M
N/A
Research and Development Expense
-27,066
+166.79%
-10,145
N/A
Depreciation and Amortization Expense
20,606
+1.01%
20,400
N/A
Total Operating Expenses
5.1M
+1.64%
5.0M
N/A
Operating Profit
-3.9M
-27.08%
-5.4M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-1.2M
+30.65%
-950,549
N/A
Interest Income and Expense and Net
-1.2M
+30.65%
-950,549
N/A
Total Nonoperating Income and Expense
-1.2M
-14.55%
-1.4M
N/A
Income before Taxes
-3.9M
-27.08%
-5.4M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
427,902
+5.51%
405,537
N/A
Net Income
-4.9M
-28.26%
-6.8M
N/A
Net Income from Continuing Operations Applicable to Common
-4.9M
-28.26%
-6.8M
N/A
Basic EPS and Net Income
-0.01
0.00%
-0.01
N/A
Diluted EPS and Net Income
-0.01
0.00%
-0.01
N/A
Basic Weighted Average Shares
504.0M
+10.75%
455.0M
N/A
Diluted Weighted Average Shares
504.0M
+10.75%
455.0M
N/A
Balance Sheet
Cash and Cash Equivalents
656,776
+3,047.44%
20,867
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
656,776
+3,047.44%
20,867
N/A
Total Current Assets
3.4M
+226.11%
1.0M
N/A
Accumulated Depreciation
77,044
+2.20%
75,388
N/A
Property and Plant and Equipment and Net
48,005
-89.32%
449,661
N/A
Total Long-Term Assets
48,425
-89.46%
459,581
N/A
Total Assets
13.3M
+654.49%
1.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
5.4M
-18.49%
6.7M
N/A
Total Current Liabilities
18.4M
+59.88%
11.5M
N/A
Total Long-Term Debt
4.6M
+1,748.40%
248,200
N/A
Total Long-Term Liabilities
4.6M
+1,748.40%
248,200
N/A
Total Liabilities
23.0M
+95.56%
11.7M
N/A
Retained Earnings
-44.4M
+12.36%
-39.5M
N/A
Total Stockholders Equity
-11.4M
+14.48%
-10.0M
N/A
Total Shares Outstanding
501.4M
+3.10%
486.3M
N/A
Cash Flow
Cash from Operating Activities
-2.1M
-43.87%
-3.7M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-573,763
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
3.3M
-11.74%
3.7M
N/A
Financials Ratio
Gross Margin
64.15%
N/A
N/A
N/A
Operating Margin
-183.20%
N/A
N/A
N/A
Return on Assets
-64.96%
N/A
N/A
N/A
Return on Equity
45.61%
N/A
N/A
N/A
Revenue Growth
228.66%
N/A
N/A
N/A
Current Ratio
0.18
N/A
N/A
N/A
Cash Ratio
0.04
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.88
N/A
N/A
N/A
Debt-to-Assets Ratio
0.75
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow